Pharmaceutical Sciences Faculty Publications
Cancer Proteomics: Many Technologies, One Goal
Document Type
Article
Publication Date
10-1-2005
Journal Title
Expert Review of Proteomics
ISSN
1744-8387
Volume
2
Issue
5
First Page
693
Last Page
703
DOI
10.1586/14789450.2.5.693
PubMed ID
16209649
Abstract
A major goal of the National Cancer Institute is to alleviate patient pain, suffering and death associated with cancer by the year 2015. This goal does not insinuate a cure for cancer, but rather the development of diagnostics and therapeutics that will eventually decrease cancer morbidity and mortality. A part of meeting this goal is to leverage the enormous data-gathering capabilities of proteomic technologies to discover disease-specific biomarkers in serum, plasma, urine, tissues and other biologic samples. The rapid advance in available technologies that have been spurred by the -omics era, has enabled biologic samples to be surveyed for biomarkers in ways never before possible. However, it is not yet clear which specific technologies will be the most successful. Therefore, proteomic laboratories within the National Cancer Institute are taking a multipronged approach to identify disease-specific biomarkers. This review discusses some of these approaches in their context of meeting the National Cancer Institute's 2015 goal.
Keywords
Animals, biomarkers, tumor, body fluids, cystitis, interstitial, humans, neoplasms, protein array analysis, proteomics
Recommended Citation
Conrads, Thomas P.; Hood, Brian L.; Petricoin, Emmanuel F.; Liotta, Lance A.; and Veenstra, Timothy D., "Cancer Proteomics: Many Technologies, One Goal" (2005). Pharmaceutical Sciences Faculty Publications. 416.
https://digitalcommons.cedarville.edu/pharmaceutical_sciences_publications/416